All three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 242 points (1.5%) at 16,127 as of Tuesday, Jan. 26, 2016, 11:55 AM ET. The NYSE advances/declines ratio sits at 2,449 issues advancing vs. 538 declining with 103 unchanged.

The Health Services industry currently sits up 0.6% versus the S&P 500, which is up 1.0%. On the negative front, top decliners within the industry include

Waters

(

WAT

), down 4.1%,

Aetna

(

AET

), down 1.1% and

CR Bard

(

BCR

), down 1.0%. Top gainers within the industry include

Community Health Systems

(

CYH

), up 5.5%,

DENTSPLY International

(

XRAY

), up 2.0%,

Abbott Laboratories

(

ABT

), up 1.2%,

Fresenius Medical Care AG & Co. KGaA

(

FMS

), up 0.6% and

Stryker Corporation

(

SYK

), up 0.5%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3.

Cigna

(

CI

) is one of the companies pushing the Health Services industry lower today. As of noon trading, Cigna is down $1.12 (-0.8%) to $134.73 on light volume. Thus far, 509,738 shares of Cigna exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $134.33-$137.44 after having opened the day at $136.82 as compared to the previous trading day's close of $135.85.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $35.5 billion and is part of the health care sector. Shares are down 7.2% year-to-date as of the close of trading on Monday. Currently there are 5 analysts that rate Cigna a buy, no analysts rate it a sell, and 5 rate it a hold.

TST Recommends

TheStreet Ratings rates

Cigna

as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Cigna Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Express Scripts

(

ESRX

) is down $0.36 (-0.5%) to $71.95 on average volume. Thus far, 1.9 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.9 million shares. The stock has ranged in price between $71.51-$72.77 after having opened the day at $71.86 as compared to the previous trading day's close of $72.31.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. Express Scripts has a market cap of $48.8 billion and is part of the health care sector. Shares are down 17.3% year-to-date as of the close of trading on Monday. Currently there are 8 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates

Express Scripts

as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income, good cash flow from operations and notable return on equity. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Express Scripts Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

UnitedHealth Group

(

UNH

) is down $0.75 (-0.7%) to $112.63 on light volume. Thus far, 1.4 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 4.0 million shares. The stock has ranged in price between $111.76-$113.45 after having opened the day at $113.14 as compared to the previous trading day's close of $113.38.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $109.0 billion and is part of the health care sector. Shares are down 3.6% year-to-date as of the close of trading on Monday. Currently there are 16 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates

UnitedHealth Group

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, solid stock price performance, reasonable valuation levels and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

UnitedHealth Group Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).